Jeff Dienhart Named Managing Director of Map of Medicine

Map of MedicineHearst Corporation announced that Jeff Dienhart has been named managing director of Map of Medicine, a subsidiary of Hearst Business Media. Dienhart succeeds Nat Billington, who has decided to leave the company. The appointment was announced today by Frank A. Bennack, Jr., vice chairman and CEO of Hearst Corporation, and Richard P. Malloch, president of Hearst Business Media, and is effective immediately.

Dienhart joins the Map from Groupe Danone, where most recently he was U.K. medical division director, responsible for commercial functions. Dienhart has 17 years of experience with blue-chip life-science companies with a prior background in management consultancy. He has also led various industry and government affairs groups and is the departing British Specialist Nutrition Association (BSNA) Chairman.

"I am very excited that Jeff is joining Map of Medicine," Malloch said. "Map of Medicine's patient pathways, based on the latest clinical evidence, have been used to improve the quality and efficiency of health care in the U.K. Jeff's senior management experience in working across the health care continuum - providers, payers and patients - will be invaluable to the growth of the company."

Regularly used by more than 7,500 clinical staff, Map of Medicine care maps are enabling clinical outcome improvements and productivity savings through local service reconfiguration across a growing range of conditions. Map of Medicine is successfully utilizing its experience gained with clients across the National Health Service (NHS) to simplify services commissioning across care settings, contributing to an improved patient experience. As the NHS faces a period of change, Map of Medicine is well positioned as the solution to address the quality, innovation, productivity and prevention (QIPP) challenge.

"I am delighted to be taking on this new role at this time, as the NHS enters a significant and challenging period of change," Dienhart said. "The Map of Medicine is ideally placed to support the increasing focus on improved productivity and patient outcomes, without sacrificing the overall care environment. We look forward to evolving alongside our health care and IT solutions partners, ensuring that the Map of Medicine's offerings continue to support the design and commissioning of optimum care maps as well as serve as a trusted information resource - leading to the best possible treatment decisions."

Related news articles:

About Map of Medicine
The ideal starting point for defining and communicating services, Map of Medicine is a collection of evidence-based, practice-informed care maps which connect all the knowledge and services around a clinical condition. Map of Medicine care maps can be customised to reflect local needs and practices, offering the opportunity to radically change the way commissioning of health and social care is planned and delivered locally. Map of Medicine is part of Hearst Business Media which is owned by Hearst Corporation, one of the world's largest diversified communications companies. For more information about Map of Medicine, visit www.mapofmedicine.com.

About Hearst Corporation
Hearst Corporation is one of the nation's largest diversified media companies. Its major interests include ownership of 15 daily and 38 weekly newspapers, including the Houston Chronicle, San Francisco Chronicle, San Antonio Express-News and Albany Times Union; nearly 200 magazines around the world, including Good Housekeeping, Cosmopolitan and O, The Oprah Magazine; 29 television stations, which reach a combined 18% of U.S. viewers; ownership in leading cable networks, including Lifetime, A&E, History and ESPN; as well as business publishing, including a minority joint venture interest in Fitch Ratings; Internet and marketing services businesses, television production, newspaper features distribution and real estate.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...